On the CV risk side, we have many biochemical markers (hyperandrogenism, estrogen/progesterone imbalance, IR, compensatory hyperinsulinemia, and low SHBG) which tell us that PCOS should be regarded as a high-risk state, while minimal CV event data show us inconclusive results. The gene discussed is SHBG; the disease is hyperandrogenism.